Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori surface structures and enzymes encompass a diverse array of molecular components essential for the bacterium's survival, colonization, and pathogenicity within the human stomach. Key enzymes include urease, which neutralizes gastric acid by producing ammonia, and various proteases and lipases that degrade the protective mucus layer (StatPearls, 2023). Surface structures such as flagella provide motility, while adhesins like BabA and SabA facilitate attachment to gastric epithelial cells (Nature Reviews Microbiology, 2017). These components are primary targets for antimicrobial therapy and vaccine development, as they are critical for the establishment of chronic infection. Targeting these structures aims to eradicate the pathogen, thereby preventing or treating conditions such as chronic gastritis, peptic ulcers, and gastric cancer (Frontiers in Microbiology, 2019). Diagnostic tools like the urea breath test directly exploit the activity of the urease enzyme to detect infection, while therapeutic challenges include the rapid development of antibiotic resistance and the protective nature of biofilms formed by these surface components (Journal of Clinical Medicine, 2020).
Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis, inhibition of urease activity, and disruption of bacterial DNA and membrane integrity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori surface structures and enzymes.